plant kiwi fruit seeds many doctors have called on the FDA to approve new weight loss treatments.But a long line of prescription weight loss offerings have been associated with safety problems

Obesity rates nearing 35 percent of the adult population, many doctors have called on the FDA to approve new weight loss treatments.But a long line of prescription weight loss offerings have been associated with safety problems, most notably the fen phen combination, which was linked to heart valve damage in 1997. The cocktail of phentermine and fenfluramine was a popular weight loss combination prescribed by doctors, though it was never approved by FDA.In a rare move, the FDA explicitly stated in a press release that Belviq “does not appear to activate” a chemical pathway that was linked to the heart problems seen with fen phen.The FDA said the drug acts on a different chemical pathway in the brain,plant kiwi fruit seeds, which is believed to reduce appetite by boosting feelings of satiety and fullness.Obesity Society President Patrick O’Neil said he’s encouraged by the drug’s approval because it underscores the idea that lifestyle changes alone are not enough to treat obesity.”This is good news because it tells us that the FDA is indeed treating obesity seriously. On the other hand, it’s not the answer to the problem or even a big part of the answer,” said O’Neil, who teaches at Medical University of South Carolina and was the lead researcher on several studies of Belviq.Even if the effects of Belviq are subtle, experts say it could be an important first step in a new line of treatments that attack the underlying causes of obesity.”The way these things tend to work is you have some people who do extremely well and other people don’t lose any weight at all.